Date published: 2026-3-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZCSL2 Inhibitors

Chemical inhibitors classified as "ZCSL2 Inhibitors" represent a compilation of compounds designed to interact with a variety of cellular components and signaling pathways, indirectly influencing the function or expression of the ZCSL2 protein. These inhibitors target a broad spectrum of molecular mechanisms, including kinase activity, phospholipase C activity, and cytoskeletal organization, illustrating the complex interplay within cellular signaling networks and the diverse approaches available for modulating protein function.

Inhibitors such as Staurosporine and LY294002 demonstrate the potential to alter kinase-dependent signaling pathways that are crucial for the regulation of a wide array of proteins, potentially including ZCSL2. By affecting these pathways, it is possible to indirectly influence the activity or expression of ZCSL2 through alterations in phosphorylation states and signaling cascades. Similarly, compounds like Rapamycin and Wortmannin, which target the mTOR and PI3K pathways respectively, play key roles in regulating cell growth, metabolism, and survival, offering potential indirect mechanisms for modulating ZCSL2 activity.

Additionally, inhibitors that target specific signaling molecules, such as CaMKII, Src family kinases, and ROCK, represented by KN-93, PP2, and Y-27632 respectively, highlight the precision with which cellular processes can be modulated to influence protein function. These inhibitors can affect calcium signaling, kinase activity, and cytoskeletal organization, which may have downstream effects on the regulation of gene expression, protein stability, and protein-protein interactions, potentially impacting the function of ZCSL2 within the cell.

This theoretical exploration into the modulation of ZCSL2 function through indirect inhibitors underscores the importance of understanding the broader cellular and molecular context in which proteins operate. By targeting signaling pathways and cellular processes relevant to the regulation of ZCSL2, insights can be gained into the potential mechanisms through which the activity of proteins like ZCSL2 can be influenced. This highlights the complexity of cellular signaling networks and the potential for multifaceted intervention strategies to modulate protein activity, providing a foundation for further investigation into the function and regulation of proteins such as ZCSL2.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Broad-spectrum kinase inhibitor, potentially affects kinase-dependent signaling pathways relevant to ZCSL2.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor, could alter AKT signaling pathways potentially involved in ZCSL2 regulation.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK1/2 inhibitor, may impact the MAPK/ERK pathway, potentially modulating ZCSL2-related signaling.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor, potentially influences stress response pathways that could affect ZCSL2 signaling.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor, might alter signaling pathways affecting ZCSL2's function or expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor, could influence protein synthesis pathways, potentially regulating ZCSL2 expression.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Inhibits CaMKII, potentially modulating calcium signaling pathways that influence ZCSL2 function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, could affect ERK pathway signaling, potentially downregulating ZCSL2 expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, potentially affects transcription factors and signaling regulating ZCSL2 expression.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$94.00
$227.00
30
(1)

Src family kinase inhibitor, could modulate signaling pathways influencing ZCSL2 activity.